Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC). This research tested a combination of treatments that could help patients live longer without their cancer getting worse. Liver cancer is a serious and deadly cancer. In 2023, liver cancer was the fourth most common cause of death globally, accounting for more than 800,000 deaths annually. Hepatocellular carcinoma represents approximately 90% of primary liver cancers. This cancer is most commonly found in people living with chronic viral hepatitis, heavy alcohol use, or metabolic dysfunction-associated steatotic liver disease. This landmark trial demonstrates...